XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Statements of Changes in Stockholders’ Equity - 3 months ended Sep. 30, 2020 - USD ($)
Class A Common Stock
Class B Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Jun. 30, 2020  
Balance (in Shares) at Jun. 30, 2020      
Class B common stock issued to Sponsor   $ 288 24,712 $ 25,000
Class B common stock issued to Sponsor (in Shares) 2,875,000 [1]      
Sale of Units in Initial Public Offering $ 1,000 99,999,000 100,000,000
Sale of Units in Initial Public Offering (in Shares) 10,000,000 [1]      
Sale of Private Placement Units $ 36 3,549,964 3,550,000
Sale of Private Placement Units (in Shares) 355,000 [1]      
Underwriting fee (2,000,000) (2,000,000)
Deferred underwriting fee (1,846,265) (1,846,265)
Offering costs charged to the stockholders’ equity (329,713) (329,713)
Change in Class A common stock subject to possible redemption $ (944) (94,357,116) (94,358,060)
Change in Class A common stock subject to possible redemption (in Shares) (9,435,806) [1]      
Net loss (40,952) (40,952)
Balance at Sep. 30, 2020 $ 92 $ 288 $ 5,040,582 $ (40,952) $ 5,000,010
Balance (in Shares) at Sep. 30, 2020 919,194 2,875,000 [1]     2,875,000
[1] Includes up to 375,000 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. The over-allotment option was not exercised by the underwriters during the 45-day option period; thus, these shares were forfeited accordingly as of November 1, 2020. (See Note 5)